MDS Virtual Congress 2021 Archives - Page 124 of 132

The study of genetic factors in motor levodopa-induced complications development in Russian patients with Parkinson’s disease

G. Akhmadeeva, I. Khidiyatova, I. Gilyazova, G. Tayupova, S. Umutbaev, A. Baitimerov, R. Magzhanov (Ufa, Russian Federation)
THE THERAPEUTIC EFFECT OF Bacopa monnieri (WATERHYSSOP) IN TREATING PARKINSON’S DISEASE

N. Nizam, M. Ramli (Shah Alam, Malaysia)
The Transcriptome from Multiple Regions of the MPTP-induced Parkinson’s disease Mouse Brain after exercise

T. Tong, Z. Zhang, Z. Zhang, H. Hu, L. Li, J. Jin (Shanghai, China)
The Use Of Bioness L300 Go Results In Functional Gait Improvement In Patients With Parkinson’s Plus Syndromes.

R. Lovell (Altadena, USA)
The use of mHealth technology to assess gait parameters of individuals with Parkinson Disease: literature review

T. de Lima, V. Domingues, T. de Freitas, C. Pasin (São Paulo, Brazil)
The volume of STN tissue activated by DBS and the strength of its structural connectivity with SMA predicts the effects of STN-DBS on response inhibition

G. Meyer, M. Albares, S. Thobois, E. Broussolle, G. Polo, P. Baraduc, B. Ballanger, ML. Welter, B. Lau, P. Boulinguez (Bron, France)
Theory of mind in patients with cerebellar neurodegenerative disorders

O. Tamas, A. Kacar, E. Stefanova, B. Salak Djokic, A. Milovanovic, D. Stanisavljevic, M. Kostic, N. Dragasevic Miskovic (Belgrade, Serbia)
Therapy to Reduce dementia risk In Parkinson’s disease (TRIP): Proof-of-concept trial

D. Pourzinal, A. Bakker, G. Byrne, K. Mcmahon, J. O'Sullivan, R. Adam, A. Lehn, D. Copland, J. Yang, G. Pontone, T. Au, R. Littleford, M. Chatfield, Z. Mari, N. Dissanayaka (Herston, Australia)
TICS WITH FITS

S. Paneyala (Mysore, India)
Time from Referral to DBS: A Single-Centre Canadian Study

K. Yen, S. Poonja, J. Miyasaki, T. Sankar, A. Shetty, F. Ba (Edmonton, Canada)